241 related articles for article (PubMed ID: 35844621)
1. CXCR6
Aviles-Padilla K; Angelo LS; Fan D; Paust S
Front Immunol; 2022; 13():886835. PubMed ID: 35844621
[TBL] [Abstract][Full Text] [Related]
2. Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia.
Giménez E; Solano C; Amat P; de la Cámara R; Nieto J; López J; Garcia-Noblejas A; Navarro D
J Med Virol; 2015 Sep; 87(9):1601-7. PubMed ID: 25802229
[TBL] [Abstract][Full Text] [Related]
3. Late Development of FcεRγ
Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M
Front Immunol; 2018; 9():1050. PubMed ID: 29868012
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of the role of NKG2C+ natural killer cells in protection from cytomegalovirus DNAemia early following allogeneic stem cell transplantation.
Muñoz-Cobo B; Giménez E; Solano C; de la Cámara R; Nieto J; López J; Amat P; Garcia-Noblejas A; Navarro D
J Med Virol; 2014 May; 86(5):806-11. PubMed ID: 24105728
[TBL] [Abstract][Full Text] [Related]
5. Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood.
Della Chiesa M; Falco M; Bertaina A; Muccio L; Alicata C; Frassoni F; Locatelli F; Moretta L; Moretta A
J Immunol; 2014 Feb; 192(4):1471-9. PubMed ID: 24442432
[TBL] [Abstract][Full Text] [Related]
6. Enrichment of Cytomegalovirus-induced NKG2C+ Natural Killer Cells in the Lung Allograft.
Harpur CM; Stankovic S; Kanagarajah A; Widjaja JML; Levvey BJ; Cristiano Y; Snell GI; Brooks AG; Westall GP; Sullivan LC
Transplantation; 2019 Aug; 103(8):1689-1699. PubMed ID: 30461721
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.
Foley B; Cooley S; Verneris MR; Pitt M; Curtsinger J; Luo X; Lopez-Vergès S; Lanier LL; Weisdorf D; Miller JS
Blood; 2012 Mar; 119(11):2665-74. PubMed ID: 22180440
[TBL] [Abstract][Full Text] [Related]
8. HCMV-controlling NKG2C
Bozzano F; Della Chiesa M; Pelosi A; Antonini F; Ascierto ML; Del Zotto G; Moretta F; Muccio L; Luganini A; Gribaudo G; Cenderello G; Dentone C; Nicolini L; Moretta A; Moretta L; De Maria A
J Allergy Clin Immunol; 2021 Jun; 147(6):2343-2357. PubMed ID: 33493558
[TBL] [Abstract][Full Text] [Related]
9. Relationship of NKG2C Copy Number with the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets.
Muntasell A; Pupuleku A; Cisneros E; Vera A; Moraru M; Vilches C; López-Botet M
J Immunol; 2016 May; 196(9):3818-27. PubMed ID: 26994220
[TBL] [Abstract][Full Text] [Related]
10. Characterization of IFNγ-producing natural killer cells induced by cytomegalovirus reactivation after haploidentical hematopoietic stem cell transplantation.
Jin F; Lin H; Gao S; Wang H; Yan H; Guo J; Hu Z; Jin C; Wang Y; Wang Z; Zhao Y; Liu Y; Zheng X; Tan Y; Li W; Dai Y; Yang Y
Oncotarget; 2017 Jan; 8(1):51-63. PubMed ID: 27980216
[TBL] [Abstract][Full Text] [Related]
11. Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection.
Brunetta E; Fogli M; Varchetta S; Bozzo L; Hudspeth KL; Marcenaro E; Moretta A; Mavilio D
AIDS; 2010 Jan; 24(1):27-34. PubMed ID: 19910789
[TBL] [Abstract][Full Text] [Related]
12. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.
Béziat V; Dalgard O; Asselah T; Halfon P; Bedossa P; Boudifa A; Hervier B; Theodorou I; Martinot M; Debré P; Björkström NK; Malmberg KJ; Marcellin P; Vieillard V
Eur J Immunol; 2012 Feb; 42(2):447-57. PubMed ID: 22105371
[TBL] [Abstract][Full Text] [Related]
13. NKG2C Natural Killer Cells in Bronchoalveolar Lavage Are Associated With Cytomegalovirus Viremia and Poor Outcomes in Lung Allograft Recipients.
Calabrese DR; Chong T; Wang A; Singer JP; Gottschall M; Hays SR; Golden JA; Kukreja J; Lanier LL; Tang Q; Greenland JR
Transplantation; 2019 Mar; 103(3):493-501. PubMed ID: 30211828
[TBL] [Abstract][Full Text] [Related]
14. Adaptive Features of Natural Killer Cells in Multiple Sclerosis.
Moreira A; Alari-Pahissa E; Munteis E; Vera A; Zabalza A; Llop M; Villarrubia N; Costa-García M; Álvarez-Lafuente R; Villar LM; López-Botet M; Martínez-Rodríguez JE
Front Immunol; 2019; 10():2403. PubMed ID: 31681293
[TBL] [Abstract][Full Text] [Related]
15. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.
Gumá M; Budt M; Sáez A; Brckalo T; Hengel H; Angulo A; López-Botet M
Blood; 2006 May; 107(9):3624-31. PubMed ID: 16384928
[TBL] [Abstract][Full Text] [Related]
16. Mass cytometry reveals single-cell kinetics of cytotoxic lymphocyte evolution in CMV-infected renal transplant patients.
Ishiyama K; Arakawa-Hoyt J; Aguilar OA; Damm I; Towfighi P; Sigdel T; Tamaki S; Babdor J; Spitzer MH; Reed EF; Sarwal MM; Lanier LL;
Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35181606
[TBL] [Abstract][Full Text] [Related]
17. NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence.
Heath J; Newhook N; Comeau E; Gallant M; Fudge N; Grant M
J Immunol Res; 2016; 2016():7470124. PubMed ID: 27314055
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
[TBL] [Abstract][Full Text] [Related]
19. NK cells generate memory-type responses to human cytomegalovirus-infected fibroblasts.
Newhook N; Fudge N; Grant M
Eur J Immunol; 2017 Jun; 47(6):1032-1039. PubMed ID: 28475279
[TBL] [Abstract][Full Text] [Related]
20. Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen.
Foley B; Cooley S; Verneris MR; Curtsinger J; Luo X; Waller EK; Anasetti C; Weisdorf D; Miller JS
J Immunol; 2012 Nov; 189(10):5082-8. PubMed ID: 23077239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
